BRPI1013363A8 - Peptídeo para o tratamento profilático ou terapêutico de tumores da pele em estágios iniciais - Google Patents
Peptídeo para o tratamento profilático ou terapêutico de tumores da pele em estágios iniciaisInfo
- Publication number
- BRPI1013363A8 BRPI1013363A8 BRPI1013363A BRPI1013363A BRPI1013363A8 BR PI1013363 A8 BRPI1013363 A8 BR PI1013363A8 BR PI1013363 A BRPI1013363 A BR PI1013363A BR PI1013363 A BRPI1013363 A BR PI1013363A BR PI1013363 A8 BRPI1013363 A8 BR PI1013363A8
- Authority
- BR
- Brazil
- Prior art keywords
- peptide
- therapeutic treatment
- early stages
- prophylactic
- skin tumors
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title 1
- 230000000069 prophylactic effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- IUYPEUHIWDMJLM-SWHDLQTQSA-N (2s)-4-amino-2-[[(2s)-5-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s,3s)-2-[[(2s,3s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s,3r)-2-amino-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino Chemical group C1=CC=C2C(C[C@H](NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=CNC2=C1 IUYPEUHIWDMJLM-SWHDLQTQSA-N 0.000 abstract 1
- 206010029098 Neoplasm skin Diseases 0.000 abstract 1
- 208000000453 Skin Neoplasms Diseases 0.000 abstract 1
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 abstract 1
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 abstract 1
- 229950009903 disitertide Drugs 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/179—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200900694A ES2347627B1 (es) | 2009-03-06 | 2009-03-06 | Peptido para el tratamiento profilactico o terapeutico de tumores de la piel en estadios iniciales. |
| PCT/ES2010/070121 WO2010100310A1 (es) | 2009-03-06 | 2010-03-04 | Péptido para el tratamiento profiláctico o terapéutico de tumores de la piel en estadios iniciales |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI1013363A2 BRPI1013363A2 (pt) | 2016-03-29 |
| BRPI1013363A8 true BRPI1013363A8 (pt) | 2016-07-19 |
Family
ID=42709234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1013363A BRPI1013363A8 (pt) | 2009-03-06 | 2010-03-04 | Peptídeo para o tratamento profilático ou terapêutico de tumores da pele em estágios iniciais |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8658599B2 (enExample) |
| EP (1) | EP2404611A4 (enExample) |
| JP (1) | JP2012519671A (enExample) |
| CN (1) | CN102341115A (enExample) |
| AR (1) | AR075783A1 (enExample) |
| AU (1) | AU2010219857A1 (enExample) |
| BR (1) | BRPI1013363A8 (enExample) |
| CA (1) | CA2753461A1 (enExample) |
| ES (1) | ES2347627B1 (enExample) |
| MX (1) | MX2011009225A (enExample) |
| RU (1) | RU2011140477A (enExample) |
| TW (1) | TW201036625A (enExample) |
| WO (1) | WO2010100310A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014183018A2 (en) * | 2013-05-10 | 2014-11-13 | Southern Research Institute | COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES THROUGH INHIBITING TGF-β ACTIVITY |
| CN110483648A (zh) * | 2019-08-27 | 2019-11-22 | 南京安吉生物科技有限公司 | 一种融合多肽及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2146552B1 (es) | 1998-11-24 | 2001-04-16 | Inst Cientifico Tecnol Navarra | Peptidos inhibidores de tgf/31 |
| EP1722823A2 (en) * | 2004-02-27 | 2006-11-22 | Antisense Pharma GmbH | Pharmaceutical composition |
| JP5112322B2 (ja) | 2005-10-24 | 2013-01-09 | プロイェクト、デ、ビオメディシナ、シーマ、ソシエダッド、リミターダ | 免疫応答調節剤の製造におけるＴＧＦ−β１インヒビターペプチドの使用 |
| BRPI0915093A2 (pt) * | 2008-06-13 | 2015-10-27 | Proyecto Biomedicina Cima Sl | conjugados para a administração de compostos biologicamente ativos |
-
2009
- 2009-03-06 ES ES200900694A patent/ES2347627B1/es not_active Expired - Fee Related
-
2010
- 2010-03-03 AR ARP100100633A patent/AR075783A1/es not_active Application Discontinuation
- 2010-03-04 BR BRPI1013363A patent/BRPI1013363A8/pt not_active IP Right Cessation
- 2010-03-04 AU AU2010219857A patent/AU2010219857A1/en not_active Abandoned
- 2010-03-04 CA CA2753461A patent/CA2753461A1/en not_active Abandoned
- 2010-03-04 US US13/255,059 patent/US8658599B2/en not_active Expired - Fee Related
- 2010-03-04 JP JP2011552477A patent/JP2012519671A/ja active Pending
- 2010-03-04 WO PCT/ES2010/070121 patent/WO2010100310A1/es not_active Ceased
- 2010-03-04 RU RU2011140477/10A patent/RU2011140477A/ru not_active Application Discontinuation
- 2010-03-04 CN CN2010800105516A patent/CN102341115A/zh active Pending
- 2010-03-04 EP EP10748370A patent/EP2404611A4/en not_active Withdrawn
- 2010-03-04 MX MX2011009225A patent/MX2011009225A/es not_active Application Discontinuation
- 2010-03-05 TW TW099106502A patent/TW201036625A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2011009225A (es) | 2011-10-10 |
| CN102341115A (zh) | 2012-02-01 |
| WO2010100310A1 (es) | 2010-09-10 |
| TW201036625A (en) | 2010-10-16 |
| AR075783A1 (es) | 2011-04-27 |
| AU2010219857A1 (en) | 2011-10-06 |
| EP2404611A4 (en) | 2012-11-21 |
| ES2347627A1 (es) | 2010-11-02 |
| EP2404611A1 (en) | 2012-01-11 |
| BRPI1013363A2 (pt) | 2016-03-29 |
| CA2753461A1 (en) | 2010-09-10 |
| ES2347627B1 (es) | 2011-10-10 |
| RU2011140477A (ru) | 2013-04-27 |
| US20120065144A1 (en) | 2012-03-15 |
| JP2012519671A (ja) | 2012-08-30 |
| US8658599B2 (en) | 2014-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015010477A2 (pt) | combinação farmacêutica que compreende um inibidor b-raf e um inibidor de histona desacetilase e o uso dos mesmos no tratamento de doenças proliferativas | |
| BRPI1015539A2 (pt) | composições e métodos para tratamento de queimaduras | |
| AU2018201997B2 (en) | Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions | |
| BR112016027041A8 (pt) | combinações farmacêuticas para tratamento do câncer | |
| UY32919A (es) | Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, mé todos para su tratamiento y sus usos | |
| EA201290184A1 (ru) | Бензодиазепиновый ингибитор бромодомена | |
| WO2009093119A3 (en) | Use of serine protease inhibitors in the treatment of skin diseases | |
| BR112015009168A2 (pt) | composto de fórmula estrutural xi, uso de um composto, composição farmacêutica, método de tratamento de uma doença mediada pela pde4 em um sujeito, método de modulação de uma função mediada pela pde4 em um sujeito, método de alcançar um efeito em um paciente e método para inibir a pde4 | |
| IN2015DN00376A (enExample) | ||
| BRPI0919447B8 (pt) | compostos derivados de ácido 1-amino-2- ciclobutiletilborônico, composição farmacêutica e uso dos mesmos para tratar câncer | |
| BRPI0721905B8 (pt) | composto inibidor de proteassoma, sua composição farmacêutica e seu uso | |
| BR112013010310A2 (pt) | inibidores de acetil-coa carboxilase de lactama n1/n2 | |
| MX2009006327A (es) | Compuestos heterociclicos y metodos de uso de los mismos. | |
| EA201001865A1 (ru) | Противовоспалительные агенты | |
| CR11684A (es) | Dihidropirazolonas sustituidas de hif-propil-4- como inhibidores hidroxilasa | |
| BR112018005905A2 (pt) | ?composto, composição farmacêutica, métodos para evitar ou tratar uma doença ou condição, lesões de órgão, hepatotoxicidade e fígado gorduroso, e, uso de um composto? | |
| BR112012002265A2 (pt) | composições farmacêuticas para o tratamento de câncer e outras doenças ou distúrbios | |
| BRPI0911469A8 (pt) | Inibidores de gm-csf e il-17 para terapia | |
| UY33530A (es) | Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias | |
| BR112013018365A2 (pt) | "peptídeos derivados da lactoferrina humana, uso dos mesmos e composição farmacêutica" | |
| BR112016013754A2 (pt) | Recaptação de serotonina-norepinefrina inibidores (irsns) e combinações dos ligantes do receptor sigma | |
| BR112012011823A2 (pt) | métodos e composições para tratar tumores sólidos e outras malignidades | |
| BR112012015386B8 (pt) | composição oftálmica tópica | |
| BRPI0518448A2 (pt) | composiÇÕes farmacÊuticas compreendendo um derivado de camptotecina | |
| CL2015000886A1 (es) | Compuestos derivados de azaindolinas sustituidas, inhibidores de la union de proteinas smac al inhibidor de proteinas de apoptosis (iap) y/o inhibidores de la union de proteina caspasa activada a los iap; composicion farmaceutica que los comprende; metodo para tratar o mejorar un cancer; y su uso para el tratamiento terapeutico y/o profilactico del cancer. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: DIGNA BIOTECH, S.L. (ES) |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |